In silico-guided exploration of SIRT6 modulation: Discovery of new fragments hits inhibitors

Ignazio Sardo1, Giulia Culletta1, Ugo Perricone2

  • 1Department of Biological, Chemical and Pharmaceutical Sciences and Technologies (STEBICEF), University of Palermo, Via Archirafi 32, 90123, Palermo, Italy.

Insights

Researchers explored Sirtuin 6 (SIRT6) inhibitors for cancer therapy. Computational methods identified promising compounds, including 9, 10, and 13, for developing novel anticancer agents targeting SIRT6.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Computational Chemistry

Background:

  • Sirtuin 6 (SIRT6) plays a critical role in DNA repair, telomere maintenance, and metabolism.
  • SIRT6's dual role in cancer and the challenge of developing selective inhibitors necessitate further research.

Purpose of the Study:

  • To investigate the molecular mechanism of SIRT6.
  • To identify novel SIRT6 inhibitors for potential anticancer applications through virtual screening.

Main Methods:

  • Docking, molecular dynamics simulations, and binding pose metadynamics were used to analyze SIRT6 structural interactions.
  • Fragment virtual screening of over 25,000 molecules was performed to identify potential inhibitors.
  • Promising compounds were selected for in vitro validation and fragment-growth strategies.

Main Results:

  • Computational analysis provided insights into SIRT6's molecular mechanism.
  • Virtual screening identified several potential SIRT6 inhibitors.
  • Compounds 9, 10, and 13 emerged as the most promising candidates for further development.

Conclusions:

  • The study successfully identified potential SIRT6 inhibitors using computational approaches.
  • These findings pave the way for designing and synthesizing new anticancer agents targeting SIRT6.
  • Further in vitro validation is warranted for the identified compounds.